Inotiv, Inc. (NOTV)
NASDAQ: NOTV · IEX Real-Time Price · USD
1.950
-0.030 (-1.52%)
At close: Jul 19, 2024, 4:00 PM
2.070
+0.120 (6.15%)
Pre-market: Jul 22, 2024, 7:07 AM EDT
Inotiv Revenue
Inotiv had revenue of $552.74M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $119.04M. In the fiscal year ending September 30, 2023, Inotiv had annual revenue of $572.43M with 4.52% growth.
Revenue (ttm)
$552.74M
Revenue Growth
-7.47%
P/S Ratio
0.09
Revenue / Employee
$268,975
Employees
2,055
Market Cap
50.64M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
Sep 30, 2021 | 89.61M | 29.14M | 48.18% |
Sep 30, 2020 | 60.47M | 16.85M | 38.64% |
Sep 30, 2019 | 43.62M | 17.27M | 65.55% |
Sep 30, 2018 | 26.35M | 2.10M | 8.68% |
Sep 30, 2017 | 24.24M | 3.80M | 18.59% |
Sep 30, 2016 | 20.44M | -2.26M | -9.94% |
Sep 30, 2015 | 22.70M | -1.89M | -7.67% |
Sep 30, 2014 | 24.58M | 2.52M | 11.40% |
Sep 30, 2013 | 22.07M | -6.14M | -21.77% |
Sep 30, 2012 | 28.21M | -4.94M | -14.89% |
Sep 30, 2011 | 33.14M | 4.36M | 15.16% |
Sep 30, 2010 | 28.78M | -3.00M | -9.45% |
Sep 30, 2009 | 31.78M | -9.91M | -23.77% |
Sep 30, 2008 | 41.70M | 1.94M | 4.89% |
Sep 30, 2007 | 39.75M | -3.30M | -7.65% |
Sep 30, 2006 | 43.05M | 653.00K | 1.54% |
Sep 30, 2005 | 42.40M | 5.24M | 14.11% |
Sep 30, 2004 | 37.15M | 7.31M | 24.51% |
Sep 30, 2003 | 29.84M | 3.33M | 12.54% |
Sep 30, 2002 | 26.51M | 1.24M | 4.90% |
Sep 30, 2001 | 25.27M | 6.05M | 31.48% |
Sep 30, 2000 | 19.22M | -627.64K | -3.16% |
Sep 30, 1999 | 19.85M | 1.63M | 8.92% |
Sep 30, 1998 | 18.23M | 3.30M | 22.12% |
Sep 30, 1997 | 14.92M | 2.13M | 16.64% |
Sep 30, 1996 | 12.79M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cidara Therapeutics | 46.38M |
Atara Biotherapeutics | 34.70M |
Ocuphire Pharma | 19.01M |
LAVA Therapeutics | 13.63M |
DURECT | 8.32M |
vTv Therapeutics | 1.00M |
NOTV News
- 6 weeks ago - Inotiv, Inc. Provides Business Updates - GlobeNewsWire
- 6 weeks ago - Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility - GlobeNewsWire
- 2 months ago - Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences - GlobeNewsWire
- 2 months ago - Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Inotiv, Inc. (NOTV) - Business Wire
- 2 months ago - Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update - GlobeNewsWire
- 2 months ago - Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024 - GlobeNewsWire
- 2 months ago - Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results - GlobeNewsWire
- 2 months ago - INOTIV INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inotiv, Inc. - NOTV - Business Wire